GLP-1 drugs have captured global attention, but they come with limitations - tolerability issues, muscle mass loss, and potential cardiovascular risks. BioRestorative believes its cell-based ...
Planning for phase 1/2 clinical trial initiation in Australia utilizing CYWC628 to treat diabetic foot ulcers in the first half of 2026 ...
President Joseph Nyuma Boakai Sr. recently officially commissioned the newly constructed headquarters and ...
News Medical on MSN
Innovating Texture and Culture in Plant-Based Foods
In this interview, News Medical-Life Sciences speaks with Gabi Saavedra, Application Specialist at Thermo Fisher Scientific, about the evolving landscape of plant-based foods, including how scientific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results